id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-N-0129-0014,FDA,FDA-2012-N-0129,Agency Information Collection Activities; Proposed Additional Collection; Comment Request; General Licensing Provisions; Section 351(k) Biosimilar Applications; Formal Meetings Between the Food and Drug Administration and Sponsors or Applicants,Notice,60 Day Proposed Information Collection,2019-11-22T05:00:00Z,2019,11,2019-11-22T05:00:00Z,2020-01-22T04:59:59Z,2019-11-22T14:28:29Z,2019-25328,0,0,0900006484197e92
FDA-2012-N-0129-0015,FDA,FDA-2012-N-0129,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Notice of Approval,2019-11-22T05:00:00Z,2019,11,2019-11-22T05:00:00Z,,2019-11-22T16:45:10Z,2019-07467,0,0,0900006483bad4d0